Rep. Maxine Dexter proposes US House bill for greater dietary supplement disclosure

A new bill sponsored by Rep. Maxine Dexter in the U.S. House is designed to strengthen oversight and transparency of dietary supplements by requiring expanded industry reporting, as recorded by the U.S. Congress.

Designated as H.R.8370, the bill was presented on April 20, 2026, during the 119th Congress’ regular session. Below is a summary reflecting the text of the bill and includes interpretation aimed at clarifying its content.

Essentially, the legislation seeks to amend the Federal Food, Drug, and Cosmetic Act to require the listing of dietary supplements with the Secretary of Health and Human Services. Companies manufacturing, packaging, or distributing dietary supplements must provide detailed information—including product names, ingredients, and labels. Existing products would need to be registered within 18 months of enactment starting Jan. 1, 2027; new products require timely listing at launch. The Secretary is charged with maintaining a public electronic database listing this information, while specific confidential data would be withheld. Funding to carry out these measures would be appropriated through 2030. The bill’s measures are meant to bolster regulatory review and strengthen public knowledge concerning dietary supplements.

Rep. Maxine Dexter (D-OR-3rd District) is the sole sponsor of the bill.

During this Congress, Dexter has put forward an additional 11 bills, with one having succeeded in being adopted.

The Senate saw the introduction of a companion measure, S.3677, on Jan. 15, 2026, which is identified in congressional documents as related legislation to H.R.8370.

Bills in Congress may originate in either the House or Senate, except for revenue bills that are required to start in the House. After a bill’s introduction, it is assigned to proper committees for evaluation, hearings, revisions and debate before possibly advancing to a chamber vote. Upon passage in both House and Senate in identical form, it is presented to the president for approval or a veto. Congress meets in two-year periods that are numbered in sequence; each period has two annual sessions. Official legislative records and the progress of bills are tracked and published through Congress.gov.

Maxine Dexter represents Oregon in the U.S. House, elected as a Democrat to the 119th Congress. She previously served from 2020 to 2024 in the Oregon House of Representatives, and holds a B.A. and M.D. from the University of Washington.

Information in this story originates from the U.S. Congress. Source data is available here.